Circ-ADD3 facilitated the binding of CDK1 and EZH2 by directly interacting with them, leading to subsequent ubiquitination and degradation and ultimately restraining HCC metastasis (61). The gene discussed is EZH2; the disease is hepatocellular carcinoma.